Matt Harris
Managing Director
Cardiology
Clarity Pharmaceuticals
Australia
Biography
Matt brings experience in biotechnology, pharmaceuticals, regulatory requirements, academic research and investment to Clarity. Matt has held leading managerial positions in Australian industry including CEO of Gateway Capital, an investment firm operating in the life science sector, CEO of an ASX listed medical device company and CEO of a start-up biopharmaceutical company. In addition, Matt has worked closely with government and regulatory agencies, as a former member of a drug evaluation committee within the Australian Therapeutics Goods Administration (TGA). Matt is currently the principal and co-founder of TM Ventures.
Research Interest
Pharmaceutical industryÂ
